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Abstract
Solid lipid microparticles produced with a mixture of cupuacu butter and stearic acid were used to
microencapsulate a commercial casein hydrolysate (Hyprol 8052). The composition of the lipid matrix
used for the production of the lipid microparticles was chosen according to data on the wide angle X-ray
diraction (WAXD) and dierential scanning calorimetry (DSC) of bulk lipid mixtures, which indicated
that the presence of 10 % cupuacu butter was sucient to signicantly change the crystalline arrange-
ment of pure stearic acid. Preliminary tests indicated that a minimum proportion of 4 % of surfactant
(polysorbate 80) was necessary to produce empty spherical lipid particles with average diameters below
10 m. The lipid microparticles were produced using 20 % cupuacu butter and 80 % stearic acid and
then stabilized with 4 % of polysorbate 80, exhibiting an encapsulation eciency of approximately 74 %
of the casein hydrolysate. The melting temperature of the casein hydrolysate-loaded lipid microparticles
was detected at 65.2 ”C, demonstrating that the particles were solid at room temperature as expected
and indicating that the incorporation of peptides had not aected their thermal behavior. After 25 days
of storage, however, there was a release of approximately 30 % of the initial amount of encapsulated
casein hydrolysate. This release was not thought to have been caused by the liberation of encapsulated
casein hydrolysate. Instead, it was attributed to the possible desorption of the adsorbed peptides present
on the surface of the lipid microparticles.
Keywords: Casein hydrolysate, solid lipid particles, microencapsulation.
1 Introduction
The hydrolysis of proteins can originate in the
bioactive peptides, which are dened as specic
protein fragments whose ingestion has a posi-
tive impact on physiological functions (Korhonen,
2009; Kitts & Weiler, 2003). Several health benets
have been attributed to these hydrolysates: e.g.,
blood pressure-lowering and cholesterol-lowering
abilities, antimicrobial actions, antithrombotic ef-
fects and the enhancement of mineral absorption,
cyto- or immuno-modulatory eects, and opioid
activities (Agyei & Danquah, 2012; Cam & de
Mejia, 2012; Korhonen, 2009; Lopez Exposito &
Recio, 2006; Gauthier, Pouliot, & Saint-Sauveur,
2006; Mikkelsen, Rasmussen, Olsen, Barkholt, &
Frokiaer, 2006; Pan et al., 2006; Mercier, Gau-
thier, & Fliss, 2004; Clemente, 2000; Hartmann
& Meisel, 2007). Another important use of bioac-
tive peptides is in support of the specic clinical
needs of patients with phenylketonuria, acute and
chronic liver disease, Crohns disease, pancreati-
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tis and ulcerative colitis (Almeida & Souto, 2007;
Clemente, 2000). In particular, casein hydrolysates
have been extensively studied due to their anti-
hypertensive, anti-inammatory, immunomodula-
tory and antimicrobial actions (Agyei & Danquah,
2012; Espeche Turbay, de Moreno de LeBlanc,
Perdigon, Savoy de Giori, & Hebert, 2012; Naka-
mura et al., 2011; del Mar Contreras, Carron, Jose
Montero, Ramos, & Recio, 2009).
However, protein hydrolysates typically have un-
pleasant sensory properties (pronounced bitter-
ness and strong odor) and the diculty of dis-
persing them in aqueous formulations due to
their hydrophobicity may limit the possibilities
of their addition to food products. Some addi-
tional disadvantages of these bioactives are their
high hygroscopicity, high reactivity and high risk
of allergenicity upon ingestion (Favaro-Trindade,
Santana, Monterrey-Quintero, Trindade, & Netto,
2010; Molina Ortiz et al., 2009; Clemente, 2000).
In addition, many researchers have noted that the
bioavailability of peptides after oral administration
may be extremely low due to their instability in
the gastrointestinal tract and their low permeabil-
ity through the intestinal membrane (Moutinho,
Matos, Teixeira, & Balcao, 2012; Dai, Wang, &
Zhao, 2005; Lee & Yamamoto, 1989). The bioavail-
ability of bioactive compounds is extremely depen-
dent on a molecular mass below 700 Da; beyond
this limit, their bioavailability decreases sharply
(Moutinho et al., 2012). There is also a mini-
mum level of hydrophicity required for the macro-
molecules' permeation through the intestinal ep-
ithelium and their passive diusion. The typical
absolute oral bioavailability of most particles is
lower than 1 % (Moutinho et al., 2012; Shaji &
Patole, 2008).
Microencapsulation technologies are excellent op-
tions to overcome some of the problems described
above { high hygroscopicity, high reactivity, and
poor sensorial characteristics (Yokota, Moraes, &
Pinho, 2012; Favaro-Trindade et al., 2010; Molina
Ortiz et al., 2009) { and to improve the peptides'
resistance to gastrointestinal conditions and en-
hance their absorption in the intestine (Agyei &
Danquah, 2012; Korhonen, 2009). The encapsula-
tion of peptides in micro- or nano-sized structures
can improve their delivery capacity and decrease
the diculty of their transport across membranes,
especially if lipid-based matrices are used in the
encapsulation systems (Agyei & Danquah, 2012).
Some frequently used structured lipid-based de-
livery systems are lipid droplets (emulsions, mi-
croemulsions, nanoemulsions, and multiple emul-
sions), liposomes, coated particles (multilayer
emulsions or colloidosomes), and solid lipid parti-
cles (McClements, 2010; McClements & Li, 2010).
Solid lipid particles can be described as an emul-
sion whose liquid core was replaced by a solid
lipid (lipids that are solid at room temperature)
(Muller, Radtke, & Wissing, 2002; Mehnert &
Mader, 2001; Muller, Mader, & Gohla, 2000).
Among the advantages of using these particles to
load active ingredients are their full biodegradabil-
ity and biocompatibility and their high capacity
for incorporating hydrophobic compounds. In ad-
dition, they can be engineered to allow the con-
trolled release of the bioactive ingredient and pro-
tect the sensitive and labile molecules from degra-
dation, using processes that can be scaled up and
that employ no organic solvents (Fathi, Mozafari,
& Mohebbi, 2012; Moutinho et al., 2012). Solid
lipid particles are an extremely interesting deliv-
ery system with multiple potential applications in
the food industry. They are of particular interest
to the manufacturers of functional foods who are
seeking novel ways to include lipophilic but chem-
ically sensitive bioactive compounds (Weiss et al.,
2008). Solid lipid particles are also of great interest
in the pharmaceutical eld for the encapsulation of
proteins and peptides, as attested by numerous pa-
pers cited by Moutinho et al. (2012) and Almeida
and Souto (2007).
The main aim of this investigation was to produce
solid lipid microparticles composed of cupuacu
butter and stearic acid for the encapsulation of
a commercial casein hydrolysate (Hyprol 8052).
Cupuacu butter was chosen for two primary rea-
sons:
1. it is an important industrial product, espe-
cially in Brazil, and
2. it is low in palmitic acid, which is known
to raise cholesterol levels, and rich in stearic
acid, which is neutral in that regard (Silva
et al., 2009; Osborn & Akoh, 2002).
Stearic acid was also chosen because it is a long-
chain fatty acid that is not absorbed by the gas-
trointestinal tract (Lairon, 2009; Osborn & Akoh,
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2002). Before producing the particles, bulk lipid
mixtures of both raw materials were produced and
evaluated to choose the best combination to pro-
duce the dispersions. The lipid microparticles were
produced by ultra-agitation and stabilized with
polysorbate 80, a surfactant commonly used in
the food industry. Preliminary tests with dierent
mass percentages of cupuacu butter and polysor-
bate 80 were conducted to select the particle for-
mulation with the lowest average particle diameter.
The shelf life of the chosen formulation of lipid mi-
croparticles was analyzed in terms of the particles'
casein hydrolysate retention and their size distri-
butions.
2 Experimental
2.1 Chemicals
The cupuacu (Theobroma grandorum) butter
(obtained from cupuacu beans), hereby referred
to as CB, was a donation from Croda (Campinas,
Brazil). The composition of this butter was de-
termined by gas chromatography and according to
the ocial methods of the AOCS (1{62 and 2-66)
(AOCS, 1998). It is described in Table 1.
This fatty acid prole is in accordance with the
ndings of previous authors (Saraiva, Cabral,
Eberlin, & Catharino, 2009; Silva et al., 2009;
Lannes, Medeiros, & Gioielli, 2004), who also con-
cluded that stearic and oleic acids were the most
abundant fatty acids in cupuacu butter. Saraiva
et al. (2009) analyzed cupuacu butter via mass
spectrometry and determined that the most abun-
dant triacylglycerols in this fat are SSO ( 30 %),
OOS+SSL ( 20 %), ASO ( 13 %) and POS (
10 %) where S = stearic acid, O = oleic acid, A =
arachidonic acid and P = palmitic acid).
The stearic acid (SA) was obtained from Sigma
(St Louis, USA). Polysorbate 80 (PS80) was ob-
tained from Synth (Diadema, Brazil). Hyprol 8052
(casein hydrolysate) was donated by Kerry Bio-
science (Campinas, Brazil), and its amino acid
composition is presented in Figure 1. Hyprol
8052 also contains 9 % casein phosphopeptides
(CPP) and 21 % free amino acids, and 92 %
of the peptides have a molecular weight be-
low 5 kDa. All other reagents and organic
solvents were of analytical grade. Deionized
water was used throughout the experiments.
Figure 1: Amino acid composition of casein
hydrolysate (Hyprol 8052) (Source: Kerry Bio-
science, 2005). Glx (glutamate+glutamic acid): 21
%; proline: 10.2 %; leucine: 8.7 %; lysine: 7.3 %
(% mass).
2.2 Production of bulk lipid
matrices
Lipid mixtures containing 10 and 25 % (mass per-
centage) CB with SA making up the remaining
mass were prepared by the fusion of the two com-
ponents at 80oC in a water bath. After fusion,
the samples were kept at room temperature until
completely cooled and solidied.
2.3 Production of lipid
microparticles and evaluation
of encapsulation eciency
Lipid microparticles (LM) were produced by melt-
ing the lipid phase at, according to the formula-
tions described in Table 2. The hot surfactant so-
lution (polysorbate 80) at 80oC was mixed with
the melted lipid and submitted to ultra-agitation
(IKA T25, IKA, Germany) at 8,000 rpm for 5
min. In formulations containing the casein hy-
drolysate, it was added to the surfactant solution
to produce a nal dispersion containing 1 g casein
hydrolysateL 1. The emulsion systems were then
magnetically stirred and cooled in an ice bath to 20
”C. The dispersions of lipid particles were stored
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Table 1: The fatty acid composition of cupuacu (Theobroma grandorum) butter used in this study.
Compound % area S.D.
C16:0 palmitic 7.46 0.31
C16:1 palmitoleic 0.07 n.a.*
C17:0 margaric 0.16 n.a.
C18:0 stearic 31.55 0.35
C18:1 c,t oleic 42.54 0.21
C18:2 c linoleic 5.86 0.05
C18:3 alpha -linolenic 0.16 n.a.
C20:0 arachidic 10.02 0.41
C20:1 c gadoleic 0.35 0.01
C22:0 behenic 1.61 0.11
C24:0 lignoceric 0.23 0.01
*n.a. = not available
Table 2: Particle formulations produced in this study.
Particle Stearic Acid Cupuacu butter (%) Polysorbate 80 Deionized water
(%) (%)
10CB-2 2.70 0.30 2 q.s. 100 mL
15CB-2 2.55 0.45 2 q.s. 100 mL
15CB-4 2.55 0.45 4 q.s. 100 mL
20CB-2 2.40 0.60 2 q.s. 100 mL
20CB-4 2.40 0.60 4 q.s. 100 mL
under refrigeration (7-10 ”C).
Nonencapsulated casein hydrolysate was separated
by ultraltration through a cellulose membrane
(cut-o molecular weight of 100 kDa, YM100, Mil-
lipore) and quantied for total protein using the
Lowry method as modied by Peterson (1979).
The encapsulation eciency was determined by
the following equation:
EE(%) = 100 
original mass of CH in the surfactant solution-mass of non encapsulated CH
original mass of CH in the surfactant solution
(1)
2.4 Determination of particle size
distribution
The particle size distribution was determined by
laser diraction using the Sald-201V (Shimadzu
Corporation, Japan) equipment at 25 ”C. The
samples were diluted with ultra-pure water before
the measurements.
2.5 Thermal behavior by
dierential scanning
calorimetry (DSC)
The bulk lipid mixtures were analyzed in a mi-
crocalorimeter (TA2010, controlled by the TA5000
system, both from TA Instruments, USA) with a
temperature ramp of 10 ”C.min 1 in an inert at-
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mosphere (45 mL.min 1 of N2). The reference was
an empty aluminum pan. The onset and melting
(peak) temperatures were calculated using Univer-
sal Analysis V.7 software (TA Instruments). The
crystallization index (CI) was calculated according
to the following expression:
CI (%) =
enthalpy LM
enthalpy PL
 FM  100 (2)
where enthalpy LM is the melting enthalpy of the
lipid mixture, enthalpy PL is the melting enthalpy
of the pure lipid and fM is a factor that takes the
concentration of solid lipid in the matrix into ac-
count (0.90 or 0.75 for mixtures containing 90 and
75 % solid lipid, respectively, in the case of stearic
acid) (Severino, Pinho, Souto, & Santana, 2011;
Junyaprasert, Teeranachaideekul, Souto, Boonme,
& Mueller, 2009).
DSC analyses of the liquid dispersions of LM
were conducted with scans at temperatures rang-
ing from 40 to 110 ”C (0.5 ”C.min 1) in a N-DSC
III (Calorimetry Sciences Corp., USA); deionized
water was used as a reference.
2.6 Analysis of particle morphology
by scanning electron
microscopy (SEM)
Scanning electron microscopy of LM was per-
formed using a LEO 440i (Leica Instruments, Ger-
many) with an accelerating voltage of 15 kV. Single
samples of dierent formulations were rst dried
in a desiccator and then sputtered with gold in a
Pelaron SC7620 sputter coater (Ringmer, UK) at
a covering rate of 0.51 angstrons.s 1 for 180 s, us-
ing a current of 3-5 mA, 1V and at a pressure of
2x10 2 Pa.
2.7 Analysis of crystallinity by
wide angle X-ray diraction
(WAXD)
Both bulk lipid mixtures were analyzed using an X-
ray diractometer (Phillips XPERT, copper an-
ode, =1.5418 angstroms), and data were obtained
from single scans in the range of 2 from 5 to 40”
(with steps of 0.02”) at room temperature.
2.8 Data presentation
The results of all analyses are reported as the av-
erage value of three replicates with standard devi-
ation.
3 Results and discussion
3.1 Characterization of the bulk
lipid mixtures: choice of a lipid
matrix to produce the lipid
microparticles
The WAXD data obtained for bulk pure stearic
acid, pure cupuacu butter and the mixtures of SA
and CB are presented in Figure 2. In the region
of the low values of 2 in the stearic acid dirac-
togram, peaks appear at 1.33 and 0.80 nm, which
is typical of this fatty acid (Teixeira, Garcia, Il-
harco, Goncalves da Silva, & Fernandes, 2010). It
is important to emphasize that the polymorphism
of carboxylic acids is dierent from that of tria-
cylglycerols. Normal saturated fatty acids exhibit
complex polymorphic behavior, and the crystal
forms can exist in four dierent polymorphs: A,
B, C and E (Bunjes & Unruh, 2007; Moreno et
al., 2007; Timms, 1984). Only the C form grows
upon crystallization from the melt, and this form
has also been found in the preparation of stearic
acid nanoparticles. This polymorph has a typical
orthorhombic subcell that is quite similar to the
-form of the triacylglycerols, as does form B
(Bunjes & Unruh, 2007; Timms, 1984). The peaks
obtained in this study for pure stearic acid at 0.42
and 0.38 nm are in accord with this information.
As expected, pure cupuacu butter presented an
amorphous characteristic with peaks at 0.46 nm
and 0.38 nm. The amorphous region between 2
of 16 and 25” likely hides a peak at 0.42 nm. The
peak at 0.46 nm is an indication of the presence
of the -form, and the simultaneous appearance
of peaks at 0.42 (probable) and 0.38 nm would
indicate the concurrent presence of the -form.
The presence of the -form in CB is extremely
likely, as it is a natural fat composed of a mixture
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of several types of triacylglycerols (Timms, 1984).
Figure 2: WAXD analyses of pure raw materials
(stearic acid, SA, and cupuacu butter, CB) and
bulk mixtures composed of SA and CB.
The addition of CB caused modications in the
peaks of pure SA and changed their intensities in
both analyzed mixtures. The total absence of -
form in the lipid mixtures was expected, as the
presence of SA did not allow for the presence of
a highly organized crystalline arrangement. The
increase in the intensities in the region of low val-
ues of 2 suggests that the structure was altered by
the stretching of the acyl chains, increasing the dis-
tance between the planes. In the \short-spacing"
peaks region, pure stearic acid exhibited two very
intense reections at 0.42 and 0.38 nm, linked to
an orthorhombic structure (Timms, 1984). This
structure was also observed with the addition of
cupuacu butter, which caused a sharp decrease in
the intensity of the reection at 0.42 nm and di-
minished the intensity at 0.38 nm. These decreases
in the pure stearic acid diractogram indicate that
its original structure was signicantly modied by
the presence of cupuacu butter in the lipid matrix
(Severino et al., 2011; Lin et al., 2007), although
it is likely that the predominant crystalline struc-
tures were orthorhombic subcells. The disorgani-
zation of the lipid matrix induced by the presence
of CB was also detected by the DSC data, as shown
in Table 3.
From the obtained calorimetric data, it is clear
that the addition of 10 % CB to stearic acid was
able to decrease the CI to 75 %, and 25 % CB
diminished the value to less than 60 %, indicat-
ing that the mixture of CB and SA was formed
by a less ordered structure than pure stearic acid.
A less ordered matrix favors an increasing num-
ber of voids in the structure. Therefore, it is able
to accommodate a larger amount of encapsulated
bioactive molecules, minimizing the expulsion of
these molecules during storage and enabling con-
trol over their release (Muller et al., 2002).
Therefore, with the use of the data obtained by
WAXD and DSC for the bulk lipid mixtures, it
was concluded that the addition of only 10 % CB
was enough to produce signicant modications in
the structure of SA, creating a new lipid matrix
with more imperfections in its structure. Such a
high degree of disorganization could facilitate the
encapsulation of bioactive molecules and increase
their retention, which is highly desirable in the
matrices chosen to produce solid lipid micro/nano
particles (Severino et al., 2011; Attama, Schicke,
& Mueller-Goymann, 2006).
3.2 Lipid microparticles:
production, characterization
and encapsulation of casein
hydrolysate
Preliminary studies were carried out with three
formulations (10CB-2, 15CB-2 and 20CB-2, whose
compositions are shown in Table 2) of empty LM
to test their ability to produce microparticles. The
results are presented in Figure 3.
In micrograph 3(A), it can be observed that al-
though the addition of 10 % CB was enough to
change the structure of the bulk lipid matrix, it
was not possible to form particles with this lipid
composition when using 2 % of surfactant to sta-
bilize them. Apparently, the presence of 10 % CB
did not decrease the crystallinity of the particles
and did not produce spherical particles with 2 %
polysorbate 80. The reduction in particle size rst
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Table 3: Calorimetric data of stearic acid (SA), cupuacu butter (CB) and bulk lipid mixtures.
Formulation Onset temperature Melting peak Melting enthalpy CI (%)
(T0, ”C) (Tm, ”C) (J.g 1)
Pure SA 69.1 73.4 224.0 |
10 %CB + 90 %SA 67.1 69.4 196.0 78.7
25 %CB + 75 %SA 66.0 69.8 177.7 59.5
causes an increase in the curvature of the surface
and then increases the number of lipid molecules
interacting with the surfactant. Thus, such an
increase necessitates a higher concentration of sur-
factant molecules to stabilize the particulate sys-
tem (Weiss et al., 2008).
Therefore, tests using lipid matrices containing 15
and 20 % CB were conducted. Their cumulative
distributions were obtained and are presented in
Figure 4.
a
b
c
Figure 3: Scanning electron micrographs of empty
lipid microparticles: (a) 10CB-2 (10,000x); (b)
15CB-2 (5,000x); (c) 20CB-2 (5,000x).
Figure 4: Particle size cumulative distributions for
the dierent formulations used to produce empty
lipid microparticles with mixtures of cupuacu but-
ter and stearic acid.
The size distributions in Figure 4 indicate that the
best choice for producing LM with lower average
diameter values was the formulation in which 20
% CB + 80 % SA was stabilized with 4 % polysor-
bate 80 because in this case, 80 % of the particles
had diameters below 10 m (66 % of the popu-
lation had diameters between 2.1 and 5.0 m).
Therefore, using this particle formulation, casein
hydrolysate was incorporated into the dispersions,
resulting in an encapsulation eciency of 73.94.5
%. This value was considered extremely satisfac-
tory and was comparable to the results obtained
by Barbosa et al. (2004), who also worked with
the encapsulation of casein hydrolysates in lipid
microparticles of stearic acid.
However, when comparing the size distributions
of empty and casein hydrolysate-loaded LM as de-
picted in Figure 5, it is clear that the incorporation
of casein hydrolysate changed the characteristics of
the dispersions dramatically. This increase in size
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may be due to the peptides adsorbed around the
LM, as Hyprol 8052 is surface-active (Mendanha
et al., 2009). These nonencapsulated, adsorbed
molecules were probably not separated by the ul-
traltration process; instead, they remained in the
system around the particles and may have con-
tributed to the morphological change visible via
SEM.
a
b
Figure 5: Micrographs obtained by SEM: (a)
empty lipid microparticles; (b) lipid microparti-
cles encapsulating casein hydrolysate (magnica-
tion: 2000x, both micrographs). Both systems
were produced using formulation 20CB-4.
Figure 6 presents the thermograms obtained for
empty and casein hydrolysate-loaded LM. It is
clear that the thermal behavior was not altered by
the presence of the encapsulated peptides. Due to
the heterogeneous composition of the particles, the
melting process began at 40 ”C, and the melting
peak temperature was recorded as 65.2 ”C, which
guarantees that the microparticles produced are
solid at the temperatures chosen for storage.
Figure 6: Thermograms obtained by DSC for fresh
lipid microparticles. Both systems were produced
using formulation 20CB-4.
To verify the behavior of LM over the storage pe-
riod, the dispersions were stored at two dierent
temperatures (refrigerated, between 7 and 10 ”C,
and at 25 ”C). The collected data showed that
the nal amount of liberated hydrolysate was the
same under the dierent storage conditions, at ap-
proximately 25-30 % of the initial mass of casein
hydrolysate present in the system. The only dif-
ference was that at the end of the rst week of
storage, the samples stored at 25 ”C had already
liberated 30 % of their initial amounts of casein
hydrolysate, whereas the samples under refrigera-
tion had released approximately 10 %.
The size distribution of the LM was also moni-
tored over the storage period, and the results of
this monitoring are presented in Figure 7. Un-
der storage at 25 ”C, the population with average
sizes up to 70 m increased signicantly, exhibit-
ing a tendency for their particles to break or, more
probably, to decrease in average size due to the lib-
eration of the peptides on their surfaces. The size
distribution of the LM stored under refrigeration
did not appear to change signicantly; however,
the high standard deviation values in the popula-
tion with average sizes up to 70 m may be due
to the same phenomenon of peptide desorption on
the LM surface.
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a
b
Figure 7: Particle size distribution of lipid parti-
cles encapsulating casein hydrolysate over a stor-
age period of 25 days: (a) at room temperature;
(b) under refrigeration. (Average of 3 samples 
SD).
4 Conclusions
The data obtained in this study have shown that
it is feasible to produce solid lipid microparticles
of cupuacu butter and stearic acid to encapsulate
casein hydrolysate. It was possible to select a suit-
able lipid mixture of both lipids using a minimum
of 10 % CB, according to the DSC and WAXD
data; with this mixture, lipid microparticles stabi-
lized with 4 % polysorbate 80 were produced. The
encapsulation eciency obtained was high, at ap-
proximately 74 %. The thermal behavior was not
altered by the presence of casein hydrolysate, but
the morphology was modied, likely due to the ad-
sorption of peptides on the surface of the particles.
After 25 days of storage, 30 % of the initial amount
of casein hydrolysate was liberated, probably from
the adsorbed peptides, rather than from the en-
capsulated casein. More studies are necessary to
investigate the extent of this adsorption and its im-
plications for the stability of the dispersions over
a longer period of storage.
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